Patent ID: 7186735
Filing Date: 2007-03-06
Classification: C07C,C07D

Abstract:
1. A compound of the formula I, wherein: R R R R R R optionally substituted phenyl, optionally substituted benzyl, optionally substituted heteroaryl, optionally substituted phenyl-CO—, or optionally substituted heteroaryl-CO—, wherein the optional substituents of the optionally substituted substituents are selected from one or more of the group consisting of halogen, —CN, C R R optionally substituted phenyl or optionally substituted heteroaryl, wherein the optional substituents of the optionally substituted substituents are selected from one or more of the group consisting of halogen, —CN, C R R R optionally substituted phenyl or optionally substituted heteroaryl, wherein the optional substituents of the optionally substituted phenyl and heteroaryl are selected from one or more of the group consisting of halogen, —CN, C R C aryl-(C R phenyl, indanyl or heteroaryl, wherein each phenyl, indanyl and heteroaryl is optionally substituted one or more times by halogen, —CN, C R R phenyl, indanyl or heteroaryl, wherein each phenyl, indanyl and heteroaryl is optionally substituted one or more times by halogen, —CN, C R R CF optionally substituted phenyl or optionally substituted heteroaryl, wherein the optional substituents of the optionally substituted phenyl and heteroaryl are selected from one or more of the group consisting of halogen, —CN, C R CF optionally substituted phenyl or optionally substituted heteroaryl, wherein the optional substituents of the optionally substituted phenyl and heteroaryl are selected from one or more of the group consisting of halogen, —CN, C wherein heteroaryl is a residue of a 5-membered to 10-membered, aromatic, monocyclic or bicyclic heterocycle containing one or more heteroatoms selected from the group consisting of N, O and S; wherein aryl is phenyl, naphth-1-yl or naphth-2-yl; m is 0, 1 or 2; and n is 1, or 3; or a stereoisomer or a mixture of stereoisomers in any ratio of the compound, or a pharmaceutically acceptable salt of the compound, stereoisomer or mixture of stereoisomers of the compound.